Abbott India (ABBOTINDIA) | Stock Overview & Key Data
Abbott India Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹37,000.00 on June 27, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Abbott India
ABBOTINDIA
|
535.06B Large-cap | 1.84% | -6.03% | -1.56% | -5.85% | -7.83% | -16.61% | 15.71% | 58.92% | 498.24% | 1,737.83% | 9,645.97% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
|
Torrent
TORNTPHARM
|
1.39T Large-cap | 2.12% | 2.23% | 5.56% | 19.07% | 17.04% | 40.54% | 146.00% | 215.51% | 578.42% | 2,737.14% | 10,046.95% |
|
Dr. Reddy's
DRREDDY
|
1.10T Large-cap | 0.31% | -4.28% | 0.20% | -0.09% | 2.08% | -6.39% | 29.74% | 20.69% | 112.36% | 310.53% | 902.28% |
|
Lupin
LUPIN
|
1.07T Large-cap | 0.83% | -0.14% | -0.76% | 8.63% | 8.10% | 14.69% | 176.15% | 98.45% | 56.65% | 418.49% | 2,332.69% |
Ownership & Short Interest
Calculate Your Abbott India Investment Returns
Long-Term Investment Performance Analysis
Abbott India stock price in Jul 2016 was ₹4,714.40, A ₹1,000.00 lump sum investment in Abbott India made 9 years ago would be worth approximately ₹5,569.11 today, representing a exceptional return of 456.91%. This translates to an annualized return (CAGR) of 18.92%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ABBOTINDIA's 52-week high and low?
- In the last 52 weeks, Abbott India reached a high of ₹37,000.00 (on June 27, 2025) and a low of ₹25,150.00 (on April 24, 2026).
- What is the market cap and P/E ratio for ABBOTINDIA?
- Curious about Abbott India's size and valuation? Its market capitalization stands at 535.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.14, and the forward P/E (looking ahead) is 31.06.
- Does ABBOTINDIA pay dividends? If so, what's the yield?
- Yes, Abbott India is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.41%, and the company has paid an average of ₹451.67 per share annually over the past 3 years.
- Who are Abbott India's main competitors or similar companies to consider before investing?
When looking at Abbott India, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.10% 82.23% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic -0.43% 85.44% Torrent
TORNTPHARM1.39T Healthcare Drug Manufacturers - Specialty & Generic 40.54% 146.00% Dr. Reddy's
DRREDDY1.10T Healthcare Drug Manufacturers - Specialty & Generic -6.39% 29.74% Lupin
LUPIN1.07T Healthcare Drug Manufacturers - Specialty & Generic 14.69% 176.15% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Abbott India Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Abbott India's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 33.41%, the Debt to Equity ratio from the most recent quarter is 4.55, and its Gross Profit Margin stands at 47.29%.
- What is the recent revenue and earnings growth for ABBOTINDIA?
- Looking at Abbott India's growth, its revenue over the trailing twelve months (TTM) was INR68B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.80%, and quarterly earnings saw a YoY growth of 4.20%.
- How much of ABBOTINDIA stock is held by insiders and institutions?
- Wondering who owns Abbott India stock? Company insiders (like executives and directors) hold about 75.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.81%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.